Bionime Corporation, Rightest GM250 Blood Glucose Monitoring System (17307)

Specialty: General Chemistry


Welcome to the PulseAid listing for the Bionime Corporation, Rightest GM250 Blood Glucose Monitoring System medical device. This device is used in the General Chemistry healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Chemistry healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Glucose monitoring devices (FDA cleared/home use) (K092052 | K092052) CLIA WAIVED
Effective Date: 2010-09-01

Other General Chemistry Devices:

Medical DeviceComplexity
BECKMAN SYNCHRON LX SYSTEMView Complexity
TOSOH AIA-1800View Complexity
Roche Diagnostics Cobas MiraView Complexity
Nova NucleusView Complexity
POINTE SCIENTIFIC, INC., LIQUID AST(SGOT) REAGENT SETView Complexity
Beckman Coulter Synchron LXi 725 Clinical SystemView Complexity
Beckman Coulter UniCel DxI 600 Access Immunoassay SystemView Complexity
Beckman Coulter AU600 Chemistry AnalyzerView Complexity
Abbott Spectrum CCXView Complexity
Beckman Coulter DxC 700 AU Clinical Chemistry AnalyzerView Complexity